Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Sourcing quality CBD remains challenge—podcast
In this podcast at SupplySide West, representatives of BI Nutraceuticals explore farming, extraction, dosing, regulation and other aspects of the hemp-derived CBD market.
1 Min Read
At the recent SupplySide West 2019 in Las Vegas, representatives of BI Nutraceuticals discussed the ingredient on everyone’s mind in the natural products industry: CBD. BI Nutraceuticals’ CEO, George Pontiakos, and its director of extract manufacturing, Michael Wagner, Ph.D., sat down for a podcast interview with Josh Long, legal and regulatory editor of Natural Products INSIDER. In the podcast, Pontiakos and Wagner discussed:
Challenges sourcing quality CBD products
Few companies, Pontiakos said, “have all the controls in place to ensure that what you’re providing to the consumer is correct, safe and efficacious.”
Safety concerns related to farming practices and extraction
Said Pontiakos: “A vast majority of hemp growers are brand new to the industry. Many of them never grew a tomato in their back yard let alone had a commercial farming operation.”
Commenting on extraction, Wagner said companies may lack the technical expertise to eliminate residual solvents from their extracts. “That’s a serious concern that we see in other extracts. It applies exactly to this and when you have inexperienced people doing it, you run that risk.”
The potential for adverse reactions from the combination of CBD products and prescription drugs
Whether FDA should establish a dosing limitation for CBD in dietary supplements
The eventual maturation of the market
“Those that are in it today,” Pontiakos said, “may not be there tomorrow when the bigger players decide to come in.”
Got feedback? Email Josh Long at [email protected]
About the Author
You May Also Like